Renaissance Technologies’s Citius Pharmaceuticals CTXR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,571
| Closed | -$61K | – | 3799 |
|
|
2023
Q3 | $61K | Sell |
3,571
-9,476
| -73% | -$162K | ﹤0.01% | 3363 |
|
|
2023
Q2 | $391K | Sell |
13,047
-2,924
| -18% | -$87.6K | ﹤0.01% | 2999 |
|
|
2023
Q1 | $467K | Sell |
15,971
-396
| -2% | -$11.6K | ﹤0.01% | 2919 |
|
|
2022
Q4 | $323K | Buy |
16,367
+736
| +5% | +$14.5K | ﹤0.01% | 3188 |
|
|
2022
Q3 | $473K | Buy |
15,631
+412
| +3% | +$12.5K | ﹤0.01% | 2954 |
|
|
2022
Q2 | $350K | Buy |
15,219
+13,647
| +868% | +$314K | ﹤0.01% | 3364 |
|
|
2022
Q1 | $70K | Buy |
+1,572
| New | +$70K | ﹤0.01% | 3851 |
|
|
2021
Q4 | – | Sell |
-35,540
| Closed | -$1.8M | – | 3947 |
|
|
2021
Q3 | $1.8M | Sell |
35,540
-40,394
| -53% | -$2.05M | ﹤0.01% | 2168 |
|
|
2021
Q2 | $6.61M | Buy |
75,934
+36,370
| +92% | +$3.16M | 0.01% | 1455 |
|
|
2021
Q1 | $1.76M | Buy |
39,564
+38,713
| +4,549% | +$1.72M | ﹤0.01% | 2305 |
|
|
2020
Q4 | $22K | Buy |
+851
| New | +$22K | ﹤0.01% | 3338 |
|
|
2020
Q2 | – | Sell |
-3,692
| Closed | -$55K | – | 3489 |
|
|
2020
Q1 | $55K | Buy |
+3,692
| New | +$55K | ﹤0.01% | 3309 |
|
|
2019
Q3 | – | Sell |
-2,053
| Closed | -$50K | – | 3458 |
|
|
2019
Q2 | $50K | Sell |
2,053
-808
| -28% | -$19.7K | ﹤0.01% | 3456 |
|
|
2019
Q1 | $102K | Sell |
2,861
-184
| -6% | -$6.56K | ﹤0.01% | 3297 |
|
|
2018
Q4 | $79K | Buy |
3,045
+712
| +31% | +$18.5K | ﹤0.01% | 3257 |
|
|
2018
Q3 | $100K | Buy |
+2,333
| New | +$100K | ﹤0.01% | 3244 |
|